Yıl: 2021 Cilt: 11 Sayı: 1 Sayfa Aralığı: 27 - 32 Metin Dili: İngilizce DOI: 10.26650/experimed.2021.879204 İndeks Tarihi: 03-12-2021

Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers

Öz:
Objective: Diabetes mellitus is a metabolic disease of global importance. It affects many people by reducing their quality of life and even causing death. Therefore, research on diabetes mellitus maintains its popularity and continues to develop. Chard (Beta vulgaris L. var. cicla) is commonly used in diets and is known to have alternative hypoglycemic effects in diabetic individuals. This study investigated the protective effects of chard on glycoproteins (hexose, hexosamine, fucose and sialic acid) and the advanced oxidation protein product levels in diabetic rats’ livers. Materials and Methods: For this experiment, male Sprague–Dawley rats were separated into three groups: the control; Streptozotocin (STZ)-induced diabetic rats; and STZ-induced diabetic + chard extract. Fourteen days after diabetes induction, chard extract (2 g/kg/day, gavage) was administered for 45 days. On day 60, liver samples were collected, and 10% (w/v) homogenate was prepared for the analysis of glycoprotein components and advanced oxidation protein products. Results: Levels of glycoprotein parameters that include hexose, hexosamine, fucose, and sialic acid, as well as advanced oxidation protein product levels, increased in the diabetic group. Chard extract administration curatively reverted the altered biochemical parameters. Conclusion: From the results obtained, it can be suggested that chard extract has a protective effect on the diabetic livers of rats.
Anahtar Kelime:

Diyabetik Sıçan Karaciğerinde Pazı Ekstresinin Glikoprotein Bileşikleri ve İleri Oksidasyon Protein Ürün Seviyeleri Üzerindeki Koruyucu Etkisi

Öz:
Amaç: Diyabet, yaşam kalitesini düşüren ve hatta ölüme neden olan, tüm dünyada birçok insanı etkileyen metabolik bir hastalıktır. Bu yüzden diyabet üzerine yapılan araştırmalar popülerliğini korumakta ve gelişimini devam ettirmektedir. Pazı (Beta vulgaris L. var. cicla) Türkiye'de şeker hastalarının alternatif hipoglisemik ajan olarak kullandığı bir bitkidir. Bu çalışmada pazı ekstraktının, diyabetik sıçanların karaciğer dokusunda bulunan glikoproteinler (heksoz, heksozamin, fukoz ve siyalik asit) ve ileri oksidasyon protein ürün seviyeleri üzerindeki koruyucu etkisinin araştırılması amaçlanmıştır. Gereç ve Yöntem: Deneyde kullanılan erkek Sprague-Dawley sıçanları 3 gruba ayrıldı. Kontrol sıçanları; Streptozotosin (STZ) ile diyabetik yapılan sıçanlar; pazı ekstresi verilen STZ diyabetik sıçanlar; Sıçanların diyabet olmasından on dört gün sonra, sıçanlara pazı ekstresi (2 g/kg/gün, gavaj ile) belirtilen dozda 45 gün uygulandı. 60. günde sıçan karaciğerleri çıkarıldı ve glikoproteinler ve ileri oksidasyon protein ürünlerinin analizi için %10 (w/v) karaciğer homojenizatları hazırlandı. Bulgular: Yapılan deneyler sonucunda diyabetik sıçanların glikoprotein parametreleri olan heksoz, heksozamin, fukoz, siyalik asit ve ileri oksidasyon protein ürün seviyelerinin arttığı bulunmuştur. Pazı ekstresinin uygulaması, incelenen biyokimyasal parametre değerlerinin tersine çevirdiği belirlenmiştir. Sonuç: Elde edilen sonuçlardan pazı ektresinin diyabetik sıçanlar üzerinde koruyucu bir etkiye sahip olduğu ileri sürülebilir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S. Diabetes 2030: Insights from Yesterday, Today, and Future Trends. Popul Health Manag 2017; 20: 6-12. [CrossRef ]
  • 2. Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 2004; 92: 1-21. [CrossRef ]
  • 3. Spiro RG. Glycoproteins: Their biochemistry, biology and role in human disease. N Engl J Med 1969; 281: 1043-56. [CrossRef ]
  • 4. Varki A. Biological roles of glycans. Glycobiology 2017; 27: 3-49. [CrossRef ]
  • 5. Porter-Turner MM, Sidmore JC, Khokher MA, Singh BM, Rea CA. Relationship between erythrocyte GLUT1 function and membrane glycation in type 2 diabetes. Br J Biomed Sci 2011; 68: 203-7. [CrossRef ]
  • 6. Patti ME, Virkamaki A, Landaker EJ, Kahan CR, Yki-Jarvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insülin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 1999; 48: 1562-71. [CrossRef ]
  • 7. Kalousova M, Skrha J, Zima T. Advanced glycation endproducts and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002; 51: 597-604.
  • 8. Hu X, Sato J, Oshida Y, Yu M, Bajotto G, Sato Y. Effect of Goshajinkigan (Chinese herbal medicine): Niu-che-sen-qi-wan on insulin resistance in streptozotocin induced diabetic rats. Diabetes Res Clin Pract 2003; 59: 103-11. [CrossRef ]
  • 9. Ninfali P, Antonini E, Frati A, Scarpa ES. C-Glycosyl flavonoids from Beta vulgaris cicla and betalains from Beta vulgaris rubra: Antioxidant, anticancer and antiinflammatory activities-A review. Phytother Res 2017; 31: 871-84. [CrossRef ]
  • 10. Bursal E. Kinetic properties of peroxidase enzyme from chard (Beta vulgaris Subspecies cicla) leaves. Int J Food Prop 2013; 16: 1293-303. [CrossRef ]
  • 11. Ustundag UV, Tunali S, Alev B, Ipekci H. Emekli-Alturfan E, Tunalı Akbay T, Yanardag R, Yarat A. Effects of chard (Beta vulgaris L. var. cicla) on cardiac damage in valproic acid-induced toxicity. J Food Biochem 2016; 40: 132-9. [CrossRef ]
  • 12. Sacan O, Yanardag R. Antioxidant and antiacetylcholinesterase activities of chard (Beta vulgaris L. var. cicla). Food Chem Toxicol 2010; 48, 1275-80. [CrossRef ]
  • 13. Ozsoy-Sacan O, Karabulut-Bulan O, Bolkent S, Yanardag R, Ozgey Y. Effects of chard (Beta vulgaris L. var cicla) on the liver of the diabetic rats: a morphological and biochemical study. Biosci Biotechnol Biochem 2004; 68: 1640-8. [CrossRef ]
  • 14. Gezginci-Oktayoglu S, Sacan O, Bolkent S, Ipci Y, Kabasakal L, Sener G, Yanardag R, Chard (Beta vulgaris L. var. cicla) extract ameliorates hyperglycemia by increasing GLUT2 through Akt2 and antioxidant defense in the liver of rats. Acta Histochem 2014; 116: 32-9. [CrossRef ]
  • 15. Kim I, Chin YW, Lim SW, Kim YC, Kim J. Norisoprenoids and hepatoprotective flavone glycosides from the aerial parts of Beta vulgaris var. cicla. Arch Pharm Res 2004; 27: 600-3. [CrossRef ]
  • 16. Trifunović S, Topalović A, Knežević M, Vajs V. Free radicals and antioxidants: antioxidative and other properties of Swiss chard (Beta vulgaris L. subsp cicla). Agric Forest 2015; 61: 73-97. [CrossRef ]
  • 17. Winzler RJ. Determination of serum glycoproteins. In: Glick DP, editor. Methods of Biochemical Analysis. New York: Interscience Publisher Inc 1955.p.279. [CrossRef ]
  • 18. Dische Z, Shettles LB. A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J Biol Chem 1948; 175: 595-603. [CrossRef ]
  • 19. Lorentz K, Weiss T, Kraas E. Sialic acid in human serum and cerebrospinal fluid. Comparison of methods and reference values. J Clin Chem Clin Biochem 1986; 24: 189-98. [CrossRef ]
  • 20. Witko-Sarsat V, Friedlander M, Capeillére-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-13. [CrossRef ]
  • 21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265- 75. [CrossRef ]
  • 22. Tomlinson KC, Gardiner SM, Hebden RA, Bennett T. Functionalconsequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 1992; 44: 103-50.
  • 23. Pari L, Umamaheswari, J. Antihyperglycaemic activity of Musa sapientum flowers: effect on lipid peroxidation in alloxan diabetic rats. Phytoter Res 2000; 14: 136-8. [CrossRef ]
  • 24. Muthukumaran J, Srinivasan S, Venkatesan RS, Ramachandran V, Muruganathana, U. Syringic acid, a novel natural phenolic acid, normalizes hyperglycemia with special reference to glycoprotein components in experimental diabetic rats. J Acute Dis 2013; 2: 304-9. [CrossRef ]
  • 25. Sacan O, Ertik O, Ipci Y, Kabasakal L, Sener G, Yanardag R. Protective effect of chard extract on glycoprotein compounds and enzyme activities in streptozotocin-induced hyperglycemic rat lungs. Bulg Chem Commun 2018; 50: 119-23.
  • 26. Ciftci G, Cenesiz S, Yarim GF, Nisbet O, Nisbet C, Cenesiz M, et al. Effect of fluoride exposure on serum glycoprotein pattern and sialic. Biol Trace Elem Res 2010; 133: 51-9. [CrossRef ]
  • 27. Moussa MA, Alsaeid M, Refai TM, Abdella N, Al- Sheikh N, Gomez JE. Association of serum sialic acid with cardiovascular metabolic risk factors in Kuwaiti children and adolescents with type 1 diabetes. Metabolism 2004; 53: 638-43. [CrossRef ]
  • 28. Gavella M, Lipovac V, Car A, Vucic M, Sokolic L, Rakos R. Serum sialic acid in subjects with impaired glucose tolerance and in newly diagnosed type 2 diabetic patients. Acta Diabetol 2003; 45: 95- 100. [CrossRef ]
  • 29. Piwowar A, Knapik-Kordecka M, Warwas M. AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. Diabetes Res Clin Pract 2007; 77: 188-92. [CrossRef ]
  • 30. D. Gradinaru C. Borsa C. Ionescu D. Margin, Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes. J Proteomics 2013; 92: 313-22. [CrossRef ]
APA ERTİK O, SAÇAN O, YANARDAG R, KABASAKAL L, Şener G (2021). Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers. , 27 - 32. 10.26650/experimed.2021.879204
Chicago ERTİK Onur,SAÇAN OZLEM,YANARDAG REFIYE,KABASAKAL LEVENT,Şener Göksel Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers. (2021): 27 - 32. 10.26650/experimed.2021.879204
MLA ERTİK Onur,SAÇAN OZLEM,YANARDAG REFIYE,KABASAKAL LEVENT,Şener Göksel Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers. , 2021, ss.27 - 32. 10.26650/experimed.2021.879204
AMA ERTİK O,SAÇAN O,YANARDAG R,KABASAKAL L,Şener G Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers. . 2021; 27 - 32. 10.26650/experimed.2021.879204
Vancouver ERTİK O,SAÇAN O,YANARDAG R,KABASAKAL L,Şener G Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers. . 2021; 27 - 32. 10.26650/experimed.2021.879204
IEEE ERTİK O,SAÇAN O,YANARDAG R,KABASAKAL L,Şener G "Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers." , ss.27 - 32, 2021. 10.26650/experimed.2021.879204
ISNAD ERTİK, Onur vd. "Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers". (2021), 27-32. https://doi.org/10.26650/experimed.2021.879204
APA ERTİK O, SAÇAN O, YANARDAG R, KABASAKAL L, Şener G (2021). Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers. EXPERIMED, 11(1), 27 - 32. 10.26650/experimed.2021.879204
Chicago ERTİK Onur,SAÇAN OZLEM,YANARDAG REFIYE,KABASAKAL LEVENT,Şener Göksel Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers. EXPERIMED 11, no.1 (2021): 27 - 32. 10.26650/experimed.2021.879204
MLA ERTİK Onur,SAÇAN OZLEM,YANARDAG REFIYE,KABASAKAL LEVENT,Şener Göksel Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers. EXPERIMED, vol.11, no.1, 2021, ss.27 - 32. 10.26650/experimed.2021.879204
AMA ERTİK O,SAÇAN O,YANARDAG R,KABASAKAL L,Şener G Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers. EXPERIMED. 2021; 11(1): 27 - 32. 10.26650/experimed.2021.879204
Vancouver ERTİK O,SAÇAN O,YANARDAG R,KABASAKAL L,Şener G Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers. EXPERIMED. 2021; 11(1): 27 - 32. 10.26650/experimed.2021.879204
IEEE ERTİK O,SAÇAN O,YANARDAG R,KABASAKAL L,Şener G "Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers." EXPERIMED, 11, ss.27 - 32, 2021. 10.26650/experimed.2021.879204
ISNAD ERTİK, Onur vd. "Protective Effect of Chard Extract on Glycoprotein Compounds and Advanced Oxidation Protein Product Levels in Diabetic Rat Livers". EXPERIMED 11/1 (2021), 27-32. https://doi.org/10.26650/experimed.2021.879204